Skip to content

The Dermalight psora-Comb was used in a group of 13 patients with moderate to severe scalp psoriasis

The Dermalight psora-Comb was used in a group of 13 patients with moderate to severe scalp psoriasis 1

This study undertook a comprehensive analysis of the annualized costs of various systemic therapies for the treatment of moderate-to-severe psoriasis. The Dermalight Psora-Comb was used in a group of 13 patients with moderate to severe scalp psoriasis. In conclusion, we have found the Psora-Comb to be an effective instrument in our scalp therapy program, especially when used with short contact anthralin therapy or psoralens either together or separately. Ms White sees around five patients, for example. So we use MRI quite a bit to established to worsen at any age, although as being a. Dotterud LK, Braun R: UV-B comb versus betamethasone solution in scalp psoriasis. Aliment Pharmacol Ther; 1999 Oct;13(10):1311-6 Fulltext service Download fulltext PDF of this article and others, as many as you want. Purcell-Huynh DA, Farese RV Jr, Johnson DF, Flynn LM, Pierotti V, Newland DL, Linton MF, Sanan DA, Young SG: Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.

The Dermalight psora-Comb was used in a group of 13 patients with moderate to severe scalp psoriasis 2

Article Excerpts

Article Excerpts